Judith M. Matthews - 11 Mar 2023 Form 4 Insider Report for Iterum Therapeutics plc (ITRM)

Role: Chief Financial Officer
Signature: /s/ Judith M. Matthews
Issuer symbol: ITRM
Transactions as of: 11 Mar 2023
Net transactions value: -$2,768
Form type: 4
Filing time: 14 Mar 2023, 18:00:26 UTC
Previous filing: 15 Mar 2022
Next filing: 03 Apr 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ITRM	Ordinary Shares	Award	$0	+6,666	+153%	$0.000000	11,018	11 Mar 2023	Direct	F1, F2
transaction	ITRM	Ordinary Shares	Tax liability	$2,768	-2,883	-26%	$0.9600	8,135	11 Mar 2023	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ITRM	Restricted Share Units	Options Exercise	$0	-6,666	-100%	$0.000000^*	0	11 Mar 2023	Ordinary Shares	6,666		Direct	F1, F2, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted share units ("RSUs") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs.
F2	On August 17, 2022 the Issuer effected a 1 for 15 reverse share split (the "Reverse Share Split"). The number of ordinary shares reported in this Form 4 have been adjusted to reflect the Reverse Share Split.
F3	Represents the ordinary shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted RSUs.
F4	On March 11, 2021, the reporting person was granted an award of 13,333 RSUs, 50% of which vested on March 11, 2022, with the remaining 50% having vested on March 11, 2023.